Bristol-Myers Squibb
BMY
#189
Rank
C$148.20 B
Marketcap
C$72.80
Share price
0.38%
Change (1 day)
-8.62%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): C$4.17

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is C$4.15. In 2024 the company made an earnings per share (EPS) of C-$6.17 a decrease over its 2023 EPS that were of C$5.42.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$4.17-167.63%
2024C-$6.17-213.92%
2023C$5.4230.2%
2022C$4.16-6.04%
2021C$4.43-179.29%
2020C-$5.58-281.37%
2019C$3.08-27.21%
2018C$4.23
2016C$3.73175.26%
2015C$1.35-19.83%
2014C$1.69-22.44%
2013C$2.1834.48%
2012C$1.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.40-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.60 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$28.64 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.27 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$5.17 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
C$4.24 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$14.57 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.89-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$18.19 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.34 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA